ID   ENPP3_HUMAN             Reviewed;         875 AA.
AC   O14638; Q5JTL3;
DT   19-SEP-2002, integrated into UniProtKB/Swiss-Prot.
DT   23-SEP-2008, sequence version 2.
DT   10-MAY-2017, entry version 153.
DE   RecName: Full=Ectonucleotide pyrophosphatase/phosphodiesterase family member 3;
DE            Short=E-NPP 3;
DE   AltName: Full=Phosphodiesterase I beta;
DE            Short=PD-Ibeta;
DE   AltName: Full=Phosphodiesterase I/nucleotide pyrophosphatase 3;
DE   AltName: CD_antigen=CD203c;
DE   Includes:
DE     RecName: Full=Alkaline phosphodiesterase I;
DE              EC=3.1.4.1 {ECO:0000250|UniProtKB:P06802};
DE   Includes:
DE     RecName: Full=Nucleotide pyrophosphatase;
DE              Short=NPPase;
DE              EC=3.6.1.9 {ECO:0000250|UniProtKB:P06802};
DE     AltName: Full=Nucleotide diphosphatase {ECO:0000305};
GN   Name=ENPP3; Synonyms=PDNP3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Prostate;
RX   PubMed=9344668; DOI=10.1006/geno.1997.4949;
RA   Piao J.-H., Goding J.W., Nakamura H., Sano K.;
RT   "Molecular cloning and chromosomal localization of PD-Ibeta (PDNP3), a
RT   new member of the human phosphodiesterase I genes.";
RL   Genomics 45:412-415(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Endometrium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   PROTEIN SEQUENCE OF 393-405, IDENTIFICATION AS CD203C, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=11342463; DOI=10.1182/blood.V97.10.3303;
RA   Buehring H.J., Seiffert M., Giesert C., Marxer A., Kanz L., Valent P.,
RA   Sano K.;
RT   "The basophil activation marker defined by antibody 97A6 is identical
RT   to the ectonucleotide pyrophosphatase/phosphodiesterase 3.";
RL   Blood 97:3303-3305(2001).
RN   [6]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=15072822; DOI=10.1016/j.canlet.2003.11.002;
RA   Yano Y., Hayashi Y., Sano K., Nagano H., Nakaji M., Seo Y.,
RA   Ninomiya T., Yoon S., Yokozaki H., Kasuga M.;
RT   "Expression and localization of ecto-nucleotide
RT   pyrophosphatase/phosphodiesterase I-1 (E-NPP1/PC-1) and -3 (E-
RT   NPP3/CD203c/PD-Ibeta/B10/gp130(RB13-6)) in inflammatory and neoplastic
RT   bile duct diseases.";
RL   Cancer Lett. 207:139-147(2004).
RN   [7]
RP   INDUCTION, AND POSSIBLE APPLICATION IN ALLERGY DIAGNOSIS.
RX   PubMed=15031605; DOI=10.1159/000077351;
RA   Buehring H.J., Streble A., Valent P.;
RT   "The basophil-specific ectoenzyme E-NPP3 (CD203c) as a marker for cell
RT   activation and allergy diagnosis.";
RL   Int. Arch. Allergy Immunol. 133:317-329(2004).
CC   -!- FUNCTION: Cleaves a variety of phosphodiester and phosphosulfate
CC       bonds including deoxynucleotides, nucleotide sugars, and NAD.
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: Hydrolytically removes 5'-nucleotides
CC       successively from the 3'-hydroxy termini of 3'-hydroxy-terminated
CC       oligonucleotides. {ECO:0000250|UniProtKB:P06802}.
CC   -!- CATALYTIC ACTIVITY: A nucleoside triphosphate + H(2)O = a
CC       nucleotide + diphosphate. {ECO:0000250|UniProtKB:P06802}.
CC   -!- COFACTOR:
CC       Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;
CC         Evidence={ECO:0000305};
CC       Note=Binds 2 divalent metal cations per subunit. {ECO:0000305};
CC   -!- ENZYME REGULATION: At low concentrations of ATP, a phosphorylated
CC       active site intermediate is formed which inhibits further ATP
CC       hydrolysis.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type II
CC       membrane protein {ECO:0000305}. Secreted
CC       {ECO:0000269|PubMed:11342463, ECO:0000269|PubMed:15072822}.
CC       Note=Located to the apical surface in intestinal and kidney
CC       epithelial cells. Located to the cell surface of basophils, and to
CC       the apical plasma membrane of bile duct cells. Secreted in serum,
CC       and in lumen of epithelial cells.
CC   -!- TISSUE SPECIFICITY: Expressed in bile ducts, prostate, uterus and
CC       colon. Exclusively expressed on basophils, mast cells and their
CC       progenitors. {ECO:0000269|PubMed:15072822,
CC       ECO:0000269|PubMed:9344668}.
CC   -!- INDUCTION: Up-regulated by stimulation by allergen or by cross-
CC       linking with IgE. The IgE-mediated activation is enhanced by
CC       tetradecanoyl phorbol acetate (TPA), a stimulator of the PKC
CC       pathway, and inhibited by the P13 kinase inhibitors, LY294002 and
CC       wortmannin. Up-regulated in invasive bile duct cancers.
CC       {ECO:0000269|PubMed:15031605}.
CC   -!- PTM: N-glycosylation is necessary for correct trafficking to the
CC       apical surface, but is not the apical targeting signal.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the nucleotide
CC       pyrophosphatase/phosphodiesterase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD05192.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF005632; AAC51813.1; -; mRNA.
DR   EMBL; EF560735; ABQ59045.1; -; mRNA.
DR   EMBL; AC005587; AAD05192.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL121575; CAI23322.1; -; Genomic_DNA.
DR   EMBL; AC005587; CAI23322.1; JOINED; Genomic_DNA.
DR   EMBL; AL355150; CAI23322.1; JOINED; Genomic_DNA.
DR   EMBL; AL355150; CAI40481.1; -; Genomic_DNA.
DR   EMBL; AC005587; CAI40481.1; JOINED; Genomic_DNA.
DR   EMBL; AL121575; CAI40481.1; JOINED; Genomic_DNA.
DR   EMBL; CH471051; EAW48045.1; -; Genomic_DNA.
DR   CCDS; CCDS5148.1; -.
DR   RefSeq; NP_005012.2; NM_005021.4.
DR   UniGene; Hs.486489; -.
DR   ProteinModelPortal; O14638; -.
DR   SMR; O14638; -.
DR   BioGrid; 111195; 1.
DR   IntAct; O14638; 1.
DR   MINT; MINT-6610326; -.
DR   STRING; 9606.ENSP00000350265; -.
DR   BindingDB; O14638; -.
DR   ChEMBL; CHEMBL5580; -.
DR   iPTMnet; O14638; -.
DR   PhosphoSitePlus; O14638; -.
DR   BioMuta; ENPP3; -.
DR   MaxQB; O14638; -.
DR   PaxDb; O14638; -.
DR   PeptideAtlas; O14638; -.
DR   PRIDE; O14638; -.
DR   DNASU; 5169; -.
DR   Ensembl; ENST00000357639; ENSP00000350265; ENSG00000154269.
DR   Ensembl; ENST00000414305; ENSP00000406261; ENSG00000154269.
DR   GeneID; 5169; -.
DR   KEGG; hsa:5169; -.
DR   UCSC; uc003qcu.5; human.
DR   CTD; 5169; -.
DR   DisGeNET; 5169; -.
DR   GeneCards; ENPP3; -.
DR   HGNC; HGNC:3358; ENPP3.
DR   HPA; HPA043772; -.
DR   MIM; 602182; gene.
DR   neXtProt; NX_O14638; -.
DR   OpenTargets; ENSG00000154269; -.
DR   PharmGKB; PA27793; -.
DR   eggNOG; KOG2645; Eukaryota.
DR   eggNOG; COG1524; LUCA.
DR   GeneTree; ENSGT00760000119157; -.
DR   HOGENOM; HOG000037439; -.
DR   HOVERGEN; HBG051484; -.
DR   InParanoid; O14638; -.
DR   KO; K01513; -.
DR   OMA; RTSDSQY; -.
DR   OrthoDB; EOG091G017X; -.
DR   PhylomeDB; O14638; -.
DR   TreeFam; TF330032; -.
DR   BRENDA; 3.6.1.9; 2681.
DR   Reactome; R-HSA-199220; Vitamin B5 (pantothenate) metabolism.
DR   ChiTaRS; ENPP3; human.
DR   GeneWiki; ENPP3; -.
DR   GenomeRNAi; 5169; -.
DR   PRO; PR:O14638; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000154269; -.
DR   CleanEx; HS_ENPP3; -.
DR   ExpressionAtlas; O14638; baseline and differential.
DR   Genevisible; O14638; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0035529; F:NADH pyrophosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0047429; F:nucleoside-triphosphate diphosphatase activity; IDA:BHF-UCL.
DR   GO; GO:0004551; F:nucleotide diphosphatase activity; TAS:ProtInc.
DR   GO; GO:0004528; F:phosphodiesterase I activity; TAS:ProtInc.
DR   GO; GO:0030247; F:polysaccharide binding; IEA:InterPro.
DR   GO; GO:0005044; F:scavenger receptor activity; IEA:InterPro.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0009143; P:nucleoside triphosphate catabolic process; IDA:BHF-UCL.
DR   GO; GO:0006796; P:phosphate-containing compound metabolic process; IDA:BHF-UCL.
DR   Gene3D; 3.40.720.10; -; 1.
DR   InterPro; IPR017849; Alkaline_Pase-like_a/b/a.
DR   InterPro; IPR017850; Alkaline_phosphatase_core.
DR   InterPro; IPR001604; DNA/RNA_non-sp_Endonuclease.
DR   InterPro; IPR029885; ENPP3.
DR   InterPro; IPR020821; Extracellular_endonuc_su_A.
DR   InterPro; IPR002591; Phosphodiest/P_Trfase.
DR   InterPro; IPR001212; Somatomedin_B_dom.
DR   PANTHER; PTHR10151:SF91; PTHR10151:SF91; 1.
DR   Pfam; PF01223; Endonuclease_NS; 1.
DR   Pfam; PF01663; Phosphodiest; 1.
DR   Pfam; PF01033; Somatomedin_B; 2.
DR   SMART; SM00892; Endonuclease_NS; 1.
DR   SMART; SM00477; NUC; 1.
DR   SMART; SM00201; SO; 2.
DR   SUPFAM; SSF53649; SSF53649; 1.
DR   SUPFAM; SSF90188; SSF90188; 2.
DR   PROSITE; PS00524; SMB_1; 2.
DR   PROSITE; PS50958; SMB_2; 2.
PE   1: Evidence at protein level;
KW   Complete proteome; Direct protein sequencing; Disulfide bond;
KW   Glycoprotein; Hydrolase; Membrane; Metal-binding; Polymorphism;
KW   Reference proteome; Repeat; Secreted; Signal-anchor; Transmembrane;
KW   Transmembrane helix; Zinc.
FT   CHAIN         1    875       Ectonucleotide
FT                                pyrophosphatase/phosphodiesterase family
FT                                member 3.
FT                                /FTId=PRO_0000188570.
FT   TOPO_DOM      1     11       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     12     30       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     31    875       Extracellular. {ECO:0000255}.
FT   DOMAIN       50     93       SMB 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00350}.
FT   DOMAIN       94    138       SMB 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00350}.
FT   REGION      140    510       Phosphodiesterase.
FT   REGION      605    875       Nuclease.
FT   MOTIF        78     80       Cell attachment site. {ECO:0000255}.
FT   ACT_SITE    205    205       AMP-threonine intermediate.
FT                                {ECO:0000250}.
FT   METAL       167    167       Zinc 1; catalytic. {ECO:0000250}.
FT   METAL       205    205       Zinc 1; catalytic. {ECO:0000250}.
FT   METAL       325    325       Zinc 2; catalytic. {ECO:0000250}.
FT   METAL       329    329       Zinc 2; via tele nitrogen; catalytic.
FT                                {ECO:0000250}.
FT   METAL       372    372       Zinc 1; catalytic. {ECO:0000250}.
FT   METAL       373    373       Zinc 1; via tele nitrogen; catalytic.
FT                                {ECO:0000250}.
FT   METAL       483    483       Zinc 2; via tele nitrogen; catalytic.
FT                                {ECO:0000250}.
FT   BINDING     226    226       Substrate. {ECO:0000250}.
FT   BINDING     320    320       Substrate. {ECO:0000250}.
FT   CARBOHYD    236    236       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    279    279       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    290    290       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    426    426       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    533    533       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    582    582       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    594    594       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    687    687       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    699    699       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    789    789       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     54     71       {ECO:0000255|PROSITE-ProRule:PRU00350}.
FT   DISULFID     58     89       {ECO:0000255|PROSITE-ProRule:PRU00350}.
FT   DISULFID     69     82       {ECO:0000255|PROSITE-ProRule:PRU00350}.
FT   DISULFID     75     81       {ECO:0000255|PROSITE-ProRule:PRU00350}.
FT   DISULFID     98    115       {ECO:0000255|PROSITE-ProRule:PRU00350}.
FT   DISULFID    103    133       {ECO:0000255|PROSITE-ProRule:PRU00350}.
FT   DISULFID    113    126       {ECO:0000255|PROSITE-ProRule:PRU00350}.
FT   DISULFID    119    125       {ECO:0000255|PROSITE-ProRule:PRU00350}.
FT   DISULFID    144    190       {ECO:0000255|PROSITE-ProRule:PRU00350}.
FT   DISULFID    152    364       {ECO:0000255|PROSITE-ProRule:PRU00350}.
FT   DISULFID    380    478       {ECO:0000255|PROSITE-ProRule:PRU00350}.
FT   DISULFID    429    818       {ECO:0000255|PROSITE-ProRule:PRU00350}.
FT   DISULFID    575    679       {ECO:0000255|PROSITE-ProRule:PRU00350}.
FT   DISULFID    577    664       {ECO:0000255|PROSITE-ProRule:PRU00350}.
FT   DISULFID    787    797       {ECO:0000255|PROSITE-ProRule:PRU00350}.
FT   VARIANT     620    620       V -> M (in dbSNP:rs9321309).
FT                                /FTId=VAR_018516.
FT   VARIANT     744    744       N -> H (in dbSNP:rs36094194).
FT                                /FTId=VAR_046538.
FT   VARIANT     786    786       S -> N (in dbSNP:rs17601580).
FT                                /FTId=VAR_031253.
FT   CONFLICT    122    122       R -> K (in Ref. 1; AAC51813).
FT                                {ECO:0000305}.
SQ   SEQUENCE   875 AA;  100124 MW;  629D2E33B4C45196 CRC64;
     MESTLTLATE QPVKKNTLKK YKIACIVLLA LLVIMSLGLG LGLGLRKLEK QGSCRKKCFD
     ASFRGLENCR CDVACKDRGD CCWDFEDTCV ESTRIWMCNK FRCGETRLEA SLCSCSDDCL
     QRKDCCADYK SVCQGETSWL EENCDTAQQS QCPEGFDLPP VILFSMDGFR AEYLYTWDTL
     MPNINKLKTC GIHSKYMRAM YPTKTFPNHY TIVTGLYPES HGIIDNNMYD VNLNKNFSLS
     SKEQNNPAWW HGQPMWLTAM YQGLKAATYF WPGSEVAING SFPSIYMPYN GSVPFEERIS
     TLLKWLDLPK AERPRFYTMY FEEPDSSGHA GGPVSARVIK ALQVVDHAFG MLMEGLKQRN
     LHNCVNIILL ADHGMDQTYC NKMEYMTDYF PRINFFYMYE GPAPRIRAHN IPHDFFSFNS
     EEIVRNLSCR KPDQHFKPYL TPDLPKRLHY AKNVRIDKVH LFVDQQWLAV RSKSNTNCGG
     GNHGYNNEFR SMEAIFLAHG PSFKEKTEVE PFENIEVYNL MCDLLRIQPA PNNGTHGSLN
     HLLKVPFYEP SHAEEVSKFS VCGFANPLPT ESLDCFCPHL QNSTQLEQVN QMLNLTQEEI
     TATVKVNLPF GRPRVLQKNV DHCLLYHREY VSGFGKAMRM PMWSSYTVPQ LGDTSPLPPT
     VPDCLRADVR VPPSESQKCS FYLADKNITH GFLYPPASNR TSDSQYDALI TSNLVPMYEE
     FRKMWDYFHS VLLIKHATER NGVNVVSGPI FDYNYDGHFD APDEITKHLA NTDVPIPTHY
     FVVLTSCKNK SHTPENCPGW LDVLPFIIPH RPTNVESCPE GKPEALWVEE RFTAHIARVR
     DVELLTGLDF YQDKVQPVSE ILQLKTYLPT FETTI
//
